Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B): The summary report of the 6th collaborative study by CSGMT/JEMS · MMS

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 389, Issue 1, 1997, Pages 3-122

  Morita, Takeshi ^a   Asano, Norihide ^b   Awogi, Takumi ^c   Sasaki, Yu F ^d   Sato, Sei Ichi ^e   Shimada, Hiroyasu ^f   Sutou, Sizuyo ^g   Suzuki, Takayoshi ^h   Wakata, Akihiro ⁱ   Sofuni, Toshio ^h   Hayashi, Makoto ^h  

^a Development and Medical Affairs Division   (Japan)

^b NITTO DENKO CORPORATION   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d HACHINOHE NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

^e JAPAN TOBACCO INC   (Japan)

^f DAIICHI SANKYO CO   (Japan)

^g Itoham Foods Inc   (Japan)

^h NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

ⁱ ASTELLAS PHARMA INC   (Japan)

Author keywords

CSGMT; Human carcinogen; IARC monograph; Micronucleus test

Indexed keywords

ALKANESULFONIC ACID DERIVATIVE; AMINOBIPHENYL DERIVATIVE; AZIRIDINE DERIVATIVE; AZO COMPOUND; BENZIDINE DERIVATIVE; CARCINOGEN; HYDRAZINE DERIVATIVE; NITROSO DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CARCINOGENICITY; CONTROLLED STUDY; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; STRUCTURE ACTIVITY RELATION;

ANIMALIA; RODENTIA;

EID: 0030871409     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(96)00070-8     Document Type: Article

References (137)

1. Adler, I.D., I. Ingwersen, U. Kliesch and A. El. Tarras (1988) Clastogenic effects of acrylamide in mouse bone marrow cells, Mutation Res., 206, 379-385.
2. Adler, I.D., J. Bootman, J. Favor, M. Hayashi, G. Hook, G. Schriever-Schwemmer, G. Welzl, E. Whorton and I. Yoshimura (1996) Recommendations for statistical designs of in vivo mutagenicity tests, formulated during a Statistics Workshop as a follow-up of the International Workshop on Standardisation of Genotoxicity Test Procedures, Mutation Res. (in preparation).
3. Aeschebacher, H.U. (1986) Rates of micronuclei induction in different mouse strains, Mutation Res., 164, 109-115.
4. Aeschebacher, H.U., Gottowick, D., Meier, H. and Poot, A.W. (1979) Mutagen-sensitive strain of mice, Mutation Res., 59, 301-304.
5. Albanse, R., E. Mirkova, D. Gatehouse and J. Ashby (1988) Species-specific response to the rodent carcinogens 1,2-dimethylhydrazine and 1,2-dibromo-3-chloropropane in rodent bone-marrow micronucleus assays, Mutagenesis, 3, 35-38.
6. Amacher, D.E. and S.C. Paillet (1983) The activation of procarcinogens to mutagens by cultured rat hepatocytes in the L5178Y/TK mutation assay, Mutation Res., 113, 77-88.
7. Amphlett, G.E. and G.F. Delow (1984) Statistical analysis of the micronucleus test, Mutation Res., 128, 161-166.
8. Anderson, B.E., E. Zeiger, M.D. Shelby, M.A. Resnick, D.K. Gulati, J.L. Ivett and K.S. Loveday (1990) Chromosome aberration and sister chromatid exchange test results with 42 chemicals, Environ. Mol. Mutagen., 16 (Suppl. 18), 55-137.
9. Asanami, S., K. Shimono, M. Uejima, E. Yamamura, H. Hirono and M. Takeuchi (1994) Mouse micronucleus test of β-butyrolactone and β-propiolactone, MMS Commun., 2, 109-116.
10. Ashby, J. (1994) The genotoxicity of 1,4-dioxane, Mutation Res., 322, 141-150.
11. Ashby, J. and R.W. Tennant (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res., 257, 229-306.
12. Ashby, J. and D. Paton (1993) The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures, Mutation Res., 286, 3-74.
13. Ashby, J., C.R. Richardson and Helen Tinwell (1989) Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assay, Mutagenesis, 4, 283-285.
14. Ashby, J., M. Ishidate Jr., G.D. Stoner, M.A. Morgan, F. Ratpan and R.D. Callander (1990) Studies on the genotoxicity of beryllium sulphate in vitro and in vivo, Mutation Res., 240, 217-225.
15. Ashby, J., H. Tinwell, P. Glover, P. Poorman-Allen, R. Krehl, R.D. Callander and D. Clive (1994) Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses, Environ. Mol. Mutagen., 24, 51-60.
16. Asita, A.O., M. Hayashi, Y. Kodama, A. Matsuoka, T. Suzuki and T. Sofuni (1992) Micronucleated reticulocyte induction by ethylating agents in mice, Mutation Res., 271, 29-37.
17. Benedict, W.F., J.E. Gielen, D.W. Nebert (1972) Polycyclic hydrocarbon-produced toxicity, transformation, and chromosomal aberrations as a function of aryl hydrocarbon hydroxylase activity in cell culture, Int. J. Cancer, 9, 435-451.
18. Bruce, W.R. and J.A. Heddle (1979) The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assays, Can. J. Genet. Cytol., 21, 319-333.
19. ± assays, Mutation Res., 189, 223-261.
20. Chieli, E., F. Alibomi, M. Saviozzi and G. Malvaldi (1987) Induction of micronucleated erythrocytes by primary thioamides and their metabolites in the mouse, Mutation Res., 192, 141-143.
21. Čihák, R. and M. Vontorková (1990) Activity of acrylamide in single-, double-, and triple-dose mouse bone marrow micronucleus assays, Mutation Res., 234, 125-127.
22. Cliet, I., C. Melcion and A. Cordier (1993) Lack of predictivity of bone marrow micronucleus test versus testis micronucleus test: comparison with four carcinogens, Mutation Res., 292, 105-111.
23. Coppinger, W.J., S.A. Brennan, J.H. Carver and E.D. Thompson (1984) Locus specificity of mutagenicity of 2,4-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells, Mutation Res., 135, 115-123.
24. CSGMT (The Collaborative Study Group for the Micronucleus Test) (1986) Sex difference in the micronucleus test, Mutation Res., 172, 151-163.
25. CSGMT (The Collaborative Study Group for the Micronucleus Test) (1988) Strain difference in the micronucleus test, Mutation Res., 204, 307-316.
26. CSGMT (The Collaborative Study Group for the Micronucleus Test) (1990) Single versus multiple dosing in the micronucleus test: the summary of the fourth collaborative study by CSGMT/JEMS · MMS, Mutation Res., 234, 205-222.
27. CSGMT (The Collaborative Study Group for the Micronucleus Test) (1992) Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: The summary report of the 5th collaborative study by CSGMT/JEMS · MMS, Mutation Res., 278, 83-98 [82].
28. CSGMT (The Collaborative Study Group for the Micronucleus Test) (1995) Protocol recommended by the CSGMT/JEMS · MMS for the short-term mouse peripheral blood micronucleus test, Mutagenesis, 10, 153-159.
29. De Flora, S. (1981) Study of 106 organic and inorganic compounds in the Salmonella/microsome test, Carcinogenesis, 2, 283-298.
30. Dhir, H., K. Agarwal, A. Sharma and G. Talukder (1991) Modifying role of Phyllanthus emblica and ascorbic acid against nickel clastogenicity in mice, Cancer Lett., 59, 9-18.
31. Doerr, C.L., K. Harrington-Brock and M.M. Moore (1989) Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells, Mutation Res., 222, 191-203.
32. Douglas, G.R., A.P. Hugenholtz and D.H. Blakey (1986) Genetic toxicology of phthalate esters: mutagenic and other genotoxic effects, Environ. Health Perspect., 65, 255-262.
33. Dunkel, V.C., E. Zeiger, D. Brusick, E. McCoy, D. McGregor, K. Mortelmans, H.S. Rosenkranz and V.F. Simmon (1984) Reproducibility of microsomal mutagenicity assays. I. Tests with Salmonella typhimurium and Escherichia coli using a standard protocol, Environ. Mutagen., 6(S2), 1-254.
34. Evans, H.H., M. Ricanati, M.F. Horng and J. Mencl (1989) Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains, Mutation Res., 217, 53-63.
35. Galloway, S.M., A.D. Bloom, M. Resnick, B.H. Margolin, F. Nakamura, P. Archer and E. Zeiger (1985) Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: Comparison of results for 22 compounds in two laboratories, Environ. Mutagen. 7, 1-51.
36. Galloway, S.M., M.J. Armstrong, C. Reuben, S. Colman, B. Brown, C. Cannon, A.D. Bloom, F. Nakamura, M. Ahmed, S. Duk, J. Rimpo, B.H. Margolin, M.A. Resnick, B. Anderson and E. Zeiger (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluation of 108 chemicals, Environ. Mol. Mutagen., 10 (Suppl. 10), 1-175.
37. George, E. and C. Westmoreland (1991) Evaluation of the in vivo genotoxicity of the structural analogues 2,6-diaminotoluene and 2,4-diaminotoluene using the rat micronucleus test and rat liver UDS assay, Carcinogenesis, 12, 2233-2237.
38. George, E., A.K. Wootton and D.G. Gatehouse (1990) Micronucleus induction by azobenzene and 1,2-dibromo-3-chloropropane in the rat: Evaluation of a triple-dose protocol, Mutation Res., 234, 129-134.
39. Gold, L.S., T.H. Slone, B.R. Stern and L. Bernstein (1993) Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals, Mutation Res., 286, 75-100.
40. Haworth, S., T. Lawlor, K. Mortelmans, W. Speck and Zeiger (1983) Salmonella mutagenicity test results for 250 chemicals, Environ. Mutagen., 1, 3-142.
41. Hayashi, M., Sofuni, T., Ishidate, M., Jr. (1982) High-sensitivity in micronucleus induction of a mouse strain (MS), Mutation Res., 105, 253-256.
42. Hayashi, M., S. Hashimoto, Y. Sakamoto, C. Hamada, T. Sofuni and I. Yoshimura (1994a) Statistical analysis of data in mutagenicity assays: Rodent micronucleus assay, Environ. Health Perspect. (Suppl., 102; Suppl. 1), 49-52.
43. Hayashi, M., S. Sutou, H. Shimada, S. Sato, Y.F. Sasaki and A. Wakata (1989a) Difference between intraperitoneal and oral gavage application in the micronucleus test, The 3rd collaborative study by CSGMT/JEMS · MMS, Mutation Res., 223, 329-344.
44. Hayashi, M., I. Yoshimura, T. Sofuni and M. Ishidate, Jr. (1989b) A procedure for data analysis of the rodent micronucleus test involving a historical control, Environ. Mol. Mutagen., 13, 347-356.
45. Hayashi, M., R.R. Tice, J.T. MacGregor, D. Anderson, D.H. Blakey, M. Kirsh-Volders, F.B. Oleson, Jr., F. Pacchierotti, F. Romagna, H. Shimada, S. Sutou and B. Vannier (1994b) In vivo rodent erythrocyte micronucleus assay, Mutation Res., 312, 293-304.
46. Higashikuni, N. and S. Sutou (1995) An optimal, generalized sampling time of 30 and 6 hr after double dosing in the mouse peripheral blood micronucleus test, Mutagenesis, 10, 313-319.
47. Higashikuni, N., T. Morita and S. Sutou (1994b) N-Nitrosodiethylamine induces micronuclei at doses below the maximum tolerated dose, MMS Commun. 2, 1-6.
48. IARC (1972) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 1, Some inorganic substances, chlorinated hydrocarbons, aromatic amines, N-nitroso compounds, and natural products, International Agency for Research on Cancer, Lyon (France).
49. IARC (1973) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 3, Certain polycyclic aromatic hydrocarbons and heterocyclic compounds, International Agency for Research on Cancer, Lyon (France).
50. IARC (1974a) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 4, Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents, International Agency for Research on Cancer, Lyon (France).
51. IARC (1974b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 7, Some anti-thyroid and related substances, nitrofurans and industrial chemicals, International Agency for Research on Cancer, Lyon (France).
52. IARC (1975a) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 8, Some aromatic azo compounds, International Agency for Research on Cancer, Lyon (France).
53. IARC (1975b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 9, Some aziridine, N-, S- and O-mustards and selenium, International Agency for Research on Cancer, Lyon (France).
54. IARC (1976a) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 10, Some naturally occurring substances, International Agency for Research on Cancer, Lyon (France).
55. IARC (1976b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 11, Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics, International Agency for Research on Cancer, Lyon (France).
56. IARC (1977) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 15, Some fumigants, the herbicides 2,4-D and 2,4,5-T, chlorinated dibenzodioxins and miscellaneous industrial chemicals, International Agency for Research on Cancer, Lyon (France).
57. IARC (1978a) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 16, Some aromatic amines and related nitro compounds - hair dyes, colouring agents and miscellaneous industrial chemicals, International Agency for Research on Cancer, Lyon (France).
58. IARC (1978b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 17, Some N-nitroso compounds, International Agency for Research on Cancer, Lyon (France).
59. IARC (1979) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 20, Some halogenated hydrocarbons, International Agency for Research on Cancer, Lyon (France).
60. IARC (1980) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 24, Some pharmaceutical drugs, International Agency for Research on Cancer, Lyon (France).
61. IARC (1982b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 27, Some aromatic amines, anthraquinones and nitroso compounds, and inorganic fluorides used in drinking water and dental preparations, International Agency for Research on Cancer, Lyon (France).
62. IARC (1982c) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 29, Some industrial chemicals and dyestuffs, International Agency for Research on Cancer, Lyon (France).
63. IARC (1983a) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 30, Miscellaneous pesticides, International Agency for Research on Cancer, Lyon (France).
64. IARC (1983b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 31, Some food additives, feed additives and naturally occurring substances, International Agency for Research on Cancer, Lyon (France).
65. IARC (1983c) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 32, Polynuclear aromatic compounds, Part 1, Environmental and experimental data, International Agency for Research on Cancer, Lyon (France).
66. IARC (1986) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 39, Some chemicals used in plastics and elastomers, International Agency for Research on Cancer, Lyon (France).
67. IARC (1987a) IARC monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 6, Genetic and Related Effects: An updating of IARC Monographs from Vols. 1-42, Int. Agency for Research on Cancer, Lyon (France).
68. IARC (1987b) IARC monographs on the evaluation of carcinogenic risks to humans, Suppl. 7, Overall Evaluations of Carcinogenicity, An updating of IARC Monographs from Vols. 1-42, Int. Agency for Research on Cancer, Lyon (France).
69. IARC (1990b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 49, Chromium, nickel and welding, International Agency for Research on Cancer, Lyon (France).
70. IARC (1990c) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 50, Pharmaceutical drugs, International Agency for Research on Cancer, Lyon (France).
71. IARC (1992) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 54, Occupational exposures in insecticide application and some pesticides, International Agency for Research on Cancer, Lyon (France).
72. IARC (1993b) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 57, Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines, International Agency for Research on Cancer, Lyon (France).
73. IARC (1993c) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 58, Beryllium, cadmium, mercury and exposures in the glass manufacturing industry, International Agency for Research on Cancer, Lyon (France).
74. IARC (1994) IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 60, Some industrial chemicals, International Agency for Research on Cancer, Lyon (France).
75. IARC (1995) IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 62, Wood dust and formaldehyde, International Agency for Research on Cancer, Lyon (France).
76. Ingerowski, G.H., M. Scheutwinkel-Reich and H.-J. Stan (1981) Mutagenicity studies on veterinary anabolic drugs with the Salmonella/microsome test, Mutation Res., 91, 93-98.
77. Ishidate, M. Jr. (ed) (1987) Data book of chromosomal aberration tests in vitro, L.I.C. Inc. Tokyo, p141.
78. Ishidate, M. Jr., M.C. Harnois and T. Sofuni (1988) A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures, Mutation Res., 195, 151-213.
79. Jotz, M.M. and A.D. Mitchell (1981) Effect of 20 coded chemicals on the forward mutation frequency at the thymidine kinase locus in L5178Y mouse lymphoma cells, Progress in Mutation Res., 1, 580-593.
80. Kuroki, T. and T. Matsushima (1987) Performance of short-term tests for detection of human carcinogens, Mutagenesis, 2, 33-37.
81. Leonard, A. and R. Lauwerys (1987) Mutagenicity, carcinogenicity and teratogenicity of beryllium, Mutation Res., 186, 35-42.
82. Lijinsky, W. and A.W. Andrews (1980) Mutagenicity of vinyl compounds in Salmonella typhimurium, Teratogen. Carcinogen. Mutagen., 1, 259-267.
83. Lorke, D. (1983) A new approach to practical acute toxicity testing, Arch. Toxicol., 54, 275-287.
84. Loveday, K.S., M.H. Lugo, M.A. Resnick, B.E. Anderson and E. Zeiger (1989) Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro: II. Results with 20 chemicals. Environ. Mol. Mutagen, 13, 60-94.
85. Loveday, K.S., B.E. Anderson, M.A. Resnick and E. Zeiger (1990) Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro, V: Results with 46 chemicals, Environ. Mol. Mutagen., 16, 272-303.
86. Manna, G.K. and S. Bardhan (1977) Some aspects of chloramphenicol-induced bone marrow chromosome aberrations in mice, J. Cytol. Genet., 12, 10-17.
87. Mavournin, K.H., D.H. Blakey, M.C. Cimino, M.F. Salamone and J.A. Heddle (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program, Mutation Res., 239, 29-80.
88. McFee, A.F., M.G. Abbott, D.K. Gulati and M.D. Shelby (1994) Results of mouse bone marrow micronucleus studies on 1,4-dioxane, Mutation Res., 322, 145-148.
89. - mouse lymphoma cell forward mutation assay II: 18 coded chemicals, Environ. Mol. Mutagen., 11, 91-118.
90. - mouse lymphoma cell forward mutation assay: III. 72 coded chemicals, Environ. Mol. Mutagen., 12, 85-154.
91. McGregor, D.B., A.G. Brown, S. Howgate, D. McBride, C. Riach and W.J. Caspary (1991b) Responses of L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicals, Environ. Mol. Mutagen., 17, 196-219.
92. Meli, C. and A.M. Seeberg (1990) Activity of 1,2-dimethylhydrazine in the mouse bone marrow micronucleus assay using a triple- and a single-dosing protocol, Mutation Res., 234, 155-159.
93. Mirkova, E. (1990) Activity of the human carcinogens benzidine and 2-naphthylamine in triple- and single-dose mouse bone marrow micronucleus assays: results for a combined test protocol, Mutation Res., 234, 161-163.
94. Mirkova, E.T. (1994) activity of the rodent carcinogen 1,4-dioxane in the mouse bone marrow micronucleus assay, Mutation Res., 322, 142-144.
95. Mohanty, P.K. (1987) Cytotoxic effect of nickel chloride on the somatic chromosomes of Swiss albino mice, Mus musculus, Curr. Sci., 56, 1154-1157.
96. Mohtashamipur, E., R. Triebel, H. Straeter and K. Norpoth (1987) The bone marrow clastogenicity of eight halogenated benzenes in male NMRI mice, Mutagenesis, 2, 111-113.
97. Moore, M.M., A. Amtower, C. Doerr, K.H. Brock and K.L. Dearfield (1987) Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells, Environ. Mutagen., 9, 261-267.
98. Myhr, B.C. and W.J. Caspary (1988) Evaluation of L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen., 12, S13, 103-194.
99. Nagao, M., Y. Takahashi, T. Yahagi, T. Sugimura, T. Takeda, K. Shudo and T. Okamoto (1980) Mutagenicities of β-carboline derivatives related to potent mutagens found in tryptophan pyrolysates, Carcinogenesis, 1, 451-454.
100. Nandan, S.D. and M.S. Rao (1981) A study on the mutagenicity of phenobarbitone using the micronucleus test in Swiss mice, IRCS Med. Sci., 9, 937-938.
101. Nersessians, A.K. (1992) Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests, Mutation Res., 281, 239-243.
102. Noguchi, T., M. Asakura, T. Sugiyama and T. Matsushima (1994b) N-Nitrosodi-n-propylamine induces micronuclei in partially hepatectomized rat liver but not in mouse bone marrow cells, MMS Commun., 2, 79-82.
103. ± mouse lymphoma forward mutation assay using 42 chemicals, Mutation Res., 125, 291-306.
104. Ohuchida, A., Y. Kouchi, C. Sugiyama, H. Kobayashi, H. Atai and Y. Hatakeyama (1995) The in vivo mutagenic potential of hydrazine and its derivatives, MMS Commun., 3, 15-23.
105. Peter, S., E. Palme, G. Rohrborn (1979) Mutagenicity of polycyclic hydrocarbons III. Monitoring genetic hazards of benz[a]anthracene, Acta Morphol. Acad. Sci. Hung., 27, 199-204.
106. Prival, M.J., S.J. Bell, U.D. Mitchell, M.D. Peiperl and V.L. Vaughane (1984) Mutagenicity of benzidine and benzidine congener dyes and selected mono azo dyes in a modified Salmonella assay, Mutation Res., 136, 33-48.
107. Proudlock, R.J. and J.A. Allen (1986) Micronuclei and other nuclear anomalies induced in various organs by diethylnitrosamine and 7,12-dimethylbenz[a]anthracene, Mutation Res., 174, 141-143.
108. Przybojewska, B., E. Dziubaltowska and Z. Kowalski (1984) Genotoxic effects of ethyl acrylate and methyl acrylate in the mouse evaluated by the micronucleus test, Mutation Res., 135, 189-191.
109. Richold, M. (1988) The genotoxicity of trenbolone, a synthetic steroid, Arch. Toxicol., 61, 249-258.
110. Roszinsky-Kocher, G., A. Basler and G. Rohrborn (1979) Mutagenicity of polycyclic hydrocarbons, V. Induction of sister-chromatid exchanges in vivo, Mutation Res., 66, 65-67.
111. Sala, M., Z.G. Gu, G. Moens and I. Chouroulinkov (1982) In vivo and in vitro biological effects of the flame retardants Tris(2,3-dibromopropyl) phosphate and Tris(2-chlorethyl) orthophosphate, J. Cancer Chn. Oncol., 18, 1337-1344.
112. Salamone, M.F. and M. Katz (1981) Mutagenicity of tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue, J. Natl. Cancer Inst., 66, 691-695.
113. Salamone, M.F., J.A. Heddle and M. Katz (1981) Mutagenic activity of 41 compounds in the in vivo micronucleus test, in: F.J. de Serres and J. Ashby (Eds.), Evaluation of Short-Term Tests for Carcinogens, Elsevier, New York, pp. 686-697.
114. Sanderson, B.T.S. and A.M. Clark (1993) Micronuclei in adult and foetal mice exposed in vivo to heliotrine, urethane, monocrotaline and benzidine, Mutation Res., 285, 27-33.
115. Sato, S., Kitajima, H., Konoshi, S., Takizawa, H. and Inui, N. (1987) Mouse strain difference in the induction of micronuclei by polycyclic aromatic hydrocarbons, Mutation Res., 192, 185-189.
116. Shelby, M.D. (1988) The genetic toxicity of human carcinogens and its implications, Mutation Res., 204, 3-15.
117. Shelby, M.D. and E. Zeiger (1990) Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetic tests, Mutation Res., 234, 257-261.
118. Shelby, M.D., G.L. Erexson, G.T. Hook and R.R. Tice (1993) Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals, Environ. Mol. Mutagen., 21, 160-179.
119. Shiraishi, Y. (1978) Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice, Mutation Res., 57, 313-324.
120. Shiraishi, Y. (1986) Hypersensitive character of Bloom syndrome B-lymphoblastoid cell lines usable sensitive carcinogen detection, Mutation Res., 175, 179-187.
121. Soler-Niedziela, L., X. Shi, J. Nath and T. Ong (1991) Studies on three structurally related phenylenediamines with the mouse micronucleus assay system, Mutation Res., 259, 43-48.
122. Sugiyama, C., H. Kobayashi, N. Asano, A. Ohuchida, Y. Kimura and S. Hitotsumachi (1995) In vivo and in vitro cytogenetic studies of four sex hormones, MMS Commun., 3, 1-13.
123. Sutou, S. and S. Sato (1990) Maternal effect on micronucleus induction in MS/Ae mice, Environ. Mol. Mutagen., 15, 125-130.
124. Tachi, K., S. Nishimae and K. Saito (1985) Cytogenetic effects of lead acetate on rat bone marrow cells, Arch. Environ. Health, 40, 144-147.
125. Tennant, R.W., B.H. Margolin, M.D. Shelby, E. Zeiger, J.K. Haseman, J. Spalding, W. Caspary, M. Resnick, S. Stasiewicz, B. Anderson and R. Minor (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays, Science, 236, 933-941.
126. Tinwell, H. and J. Ashby (1994) Activity of 1,4-dioxane in mouse bone marrow micronucleus assays, Mutation Res., 322, 148-150.
127. Tsuchimoto, T. and B.E. Matter (1981) Activity of coded compounds in the micronucleus test, in: F.J. de Serres and J. Ashby (Eds.), Evaluation of Short-Term Tests for Carcinogens, Elsevier, New York, pp. 705-711.
128. Venitt, S. (1986) Genetic toxicology of chromium and nickel compounds, Excerpta Med., 676, 249-266.
129. Walk, R.A., J. Jenderny, G. Röhrborn and U. Hackenberg (1987) Chromosomal abnormalities and sister-chromatid exchange in bone marrow cells of mice and Chinese hamsters after inhalation and intraperitoneal administration: I. diepoxybutane, Mutation Res., 182, 333-342.
130. Wangenheim, J. and G. Bolcsfoldi (1988) Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds, Mutagenesis, 3, 193-205.
131. Yahagi, T., M. Nagao, Y. Seino, T. Matsushima, T. Sugimura and M. Okada (1977) Mutagenicities of N-nitrosamines of Salmonella, Mutation Res., 48, 121-130.
132. You, Z., M.D. Brezzell, S.K. Das, M.C. Espadas-Torre, B.H. Hooberman and J.E. Sinsheimer (1993) ortho-Substituent effects on the in vitro and in vivo genotoxicity of benzidine derivatives, Mutation Res., 319, 19-30.
133. Youssefi, A.A., R. Arutyunyan and I. Emerit (1994) Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors, Mutation Res., 309, 185-191.
134. Zeiger, E. and S. Haworth (1985) Tests with a preincubation modification of the Salmonella/microsome assay, in: Ashby, J., F.J. de Serres et al. (Eds.), Progress in Mutation Research, Vol. 5, Elsevier Science Publishers, Amsterdam, WHO, Geneva, 187-199.
135. Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, K. Mortelmans and W. Speck (1987) Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals, Environ. Mol. Mutagen., 9, Suppl. 9, 1-110.
136. Zeiger, E., J.K. Haseman, M.D. Shelby, B.H. Margolin and R.W. Tennant (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals, Environ. Mol. Mutagen., 16 (Suppl. 18), 1-14.
137. Zeiger, E., B. Anderson, S. Haworth, T. Lawlor and K. Mortelmans (1992) Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals, Environ. Mol. Mutagen., 19, Suppl. 21, 2-141.